Hot Investor Mandate: Family Owned Company With Global Offices Manages Venture Fund Investing in Promising Projects in Anti-Aging and Neuroscience Related Indications

23 Feb

A global, family-owned company with headquarters in Europe has offices all around the world. The firm’s venture fund focuses on early stage companies, and positions itself to be a strategic corporate partner to develop and support innovative technologies to commercialization in areas for growth opportunity. The firm’s venture fund typically makes $1-$5 million investments. The firm is seeking 4-5 investments in early-stage companies, start-ups including spinout companies from academia. The firm is geographically agnostic, and is open to investments from all over the world.

The firm is seeking outstanding ideas and promising technologies that are capable of generating a high level of customer interest. Besides early stage projects and seed investments, the firm aims to maximize the value of their entire portfolio, including the development of promising later stage investments and opportunities across all aforementioned the firm’s focus areas. The firm’s interest in Aesthetics comprises an anti-aging focus, including skin rejuvenation, body shaping and modification. The firm is open to all therapeutics, medical devices, and digital health / healthcare IT, as long as the technology serves an unmet need/gap in the aesthetics professionals’ daily practice.

The firm’s Neuroscience perspective includes, but is not limited to the treatment of movement disorders and adjacent indications, while the firm’s consumer healthcare business is open applicable b2b and d2c models for improving consumers’ wellbeing and sustainable quality of life.

The firm take pride in their long-standing commitment to both innovation and continuity. In line with their strategic interests, the firm is open to proactive and long-term engagement with their partners, and hope to provide much more than financial backing.

The firm seeks to directly connect investments to the firm’s global infrastructure by offering access to relevant experts in their scientific research network and providing commercial insights into global market.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Hot Investor Mandate: USA-Based Fund Actively Seeks Therapeutics, Medtech, and Digital Health, Investing Up to $20M in Series A Financings and Beyond

23 Feb

A firm actively funds, supports and advances life science technologies from early development through clinical proof-of-concept. The firm’s experienced leadership team works with scientists and entrepreneurs to provide active mentorship, financing solutions and operational guidance to increase the probability of success in early drug development. The firm has access to capital to support companies from seed investment through Series A and B financings and the size of initial seed investment can range from $0.5M to $1.5M. The subsequent Series A investments will be sized to get through preclinical and IND-enabling work and/or through a clinical development study and can range between $8M-$20M, with flexibility to syndicate with investors for larger rounds. For more mature companies that don’t require a seed round or the need to do complete activities/studies prior to a Series A, the firm can invest directly as a Series A investment along with participation in related Series B investments. The firm is open to global opportunities.

The firm supports opportunities across all therapeutic areas and drug modalities (small molecule, peptides, antibodies, genetic technologies, cell therapy, etc.).  Additionally, the firm is open to technologies beyond drug therapeutics, including medical devices, diagnostics and emerging healthtech opportunities (digital health, telemedicine, enabling technologies utilizing AI/ML, etc.). Founder and entrepreneur friendly and supportive of first-time CEOs, the firm works side by side to drive value inflections with the goal to optimize program development and successful outcomes.

The firm is open to working with all types of management teams, including first time entrepreneurs. The firm works hands-on with its portfolio companies by bringing a powerful network, access to resources and expertise to support their growth. The firm prefers to lead but is open to participating with likeminded co-investors to form syndicates.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Hot Investor Mandate: Europe-Based Investment Firm Seeks Opportunities in Healthtech and Digital Health, Investing Up to $10M Over the Company’s Life Cycle

23 Feb

An investment firm based in Europe has been supporting innovative Technology and Healthcare companies for over 20 years, investing over $350M in 60+ startups. The firm’s funds are backed by some of the most visible companies and institutions in the industry. The firm makes allocations from $500,000 to $10M over the life of the investment, and in the life science sector allocations are typically over $5m. The firm primarily invests in companies based in Europe or with ties to Europe. Allocations to US, Canada and Israel are possible.

The firm invests in the healthtech and digital health sectors and is opportunistic within these sectors regarding indication area and technology. The firm prefers to invest in early-stage companies.

The firm seeks highly qualified, ambitious management teams, and is typically an activist investor that takes a seat on a portfolio company’s board.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Hot Investor Mandate: Family Office Invests in Seed to Early Venture Stage Medical Device & Digital Health Companies With Interests in CNS, Ophthalmology, Chronic Diseases, and More

23 Feb

A family office invests in healthcare and technology companies. The firm partner with awesome entrepreneurs who are transforming healthcare – solving big problems and creating great companies. Typical investment is $200k-1M.

The firm’s interests include chronic eye diseases, diabetes, Parkinson’s, Alzheimer’s, cancer (breast & prostate), stroke, chronic kidney disease, AI, digital health, medical devices, telemedicine. The firm does not actively invest in therapeutics or diagnostics at this time.

The firm partners with resourceful entrepreneurs who have proven their ability to get results.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

The Art of Raising Money for a Life Sciences Company

21 Feb

Some of the biggest challenges executives of early-stage life sciences companies face is securing financing and forging their first licensing deals. Though they may possess deep scientific knowledge, finding the right investors and partners, and telling their story in a compelling way may require skills they have not yet developed. Life Science Nation works with entrepreneurs to tell their stories, identify potential investors and partners, and connect with them. Daniel Levine  of Levine Media Group interviews Dennis Ford, founder and CEO of Life Science Nation, for BigBio Communications about the journey and challenges life sciences entrepreneurs make when they set out to raise money, what investors care about, and what steps they can take to best ensure their success. Listen here:

Since Fundraising is a Numbers Game – LSN is Bundling Digital RESI March and Face2Face RESI June Boston

16 Feb

By Candice He, Vice President of Business Development, Global Investment Strategist, LSN

To keep the capital investors and licensing partners meetings numbers up Life Science Nation (LSN) has put together a partnering event bundle for the next two RESI conferences. Register for both Digital RESI March and RESI Boston June until March 13 and save up to $1,000.

Launching and executing a global partnering campaign means getting out into the market and socializing your company with potential partner meetings. Combining the Digital RESI March partnering event with the face2face RESI Boston June event gives our startup companies an opportunity to create some momentum as 2023 progresses.  LSN offers a compelling price point that will able our scientist entrepreneurs and fundraising CEOs a chance to get in front of the players in the market that they need to meet.

The Digital RESI March partnering event is a full-blown virtual conference with investor panels and workshops, as well as the best partnering available. RESI Boston June features all the same compelling sessions in person at Weston Copley Place, June 5-7. Both conferences include an investor and licensing partner database curated by LSN and we fill in all the buy-side partner profiles in our partnering system. This enables the sell-side startup CEOs to search and find the strategic partners they need to establish a dialogue with. This capability makes the RESI events unique and dynamic as they can really match based on fit which make the meetings so much better.

Startup CEOs need to get into the market and the bundle opportunity will increase their odds for fundraising success. For those CEOs who are not quite ready to start partnering meetings you can go and participate in the three-day, two hour a day, entrepreneurial education program from 11-1 which will guide you through setting up and launching a global partnering campaign.  Plus, you can also take advantage of the Audience Access Pass and go to RESI for content and education.  Let’s get busy!

Digital RESI March 14-16
RESIConference.com
RESI June Boston
Westin Copley Place – June 5
Virtual Partnering only – June 6-7
Standard Bundle (March 14-16 & June 5-7) Digital Bundle (March 14-16 & June 6-7)
STARTUP $2,190 $3,190 $1,690 $2,690
SERVICE PROVIDER $2,990 $3,990 $2,290 $2,290
TECH HUB (Including Startup Who’ve Raised Less than $2MM USD ) $1,990 $2,390 $1,390 $2,390
Contact us to discuss further

Register-now-button-new

RESI-Boston-2023-June-1100px-border

RESI-Boston-2023-June-1100px

How to Improve your Partnering Metrics at RESI

16 Feb

By Karen Deyo, Director of Investor Research, Israel BD, LSN

Life Science Nation (LSN) knows why startups fail at partnering events, and it is mostly a lack of experience and knowledge, which puts the startup out of context. For example, it starts with very simple things, such as not understanding the importance of the tagline. If you are an investor receiving hundreds of meeting requests, you do not have the time to do a deep dive into every message. The company that nets out who they are with a compelling tagline that can be quickly skimmed and then get an affirmative meeting request clicked is how it is done right. You should be able to get a meeting just by the potential partner reading your tagline. The same rules apply to your company’s elevator pitch. A tagline is 5-7 words that net out who you are and what you do. A potential partner should be able to read your tagline and have enough information to either take a meeting or go on and read more…your elevator pitch is 5-7 sentences that net out who you are and what you do in more detail.  Again, from reading the elevator pitch should be able to decide whether take a meeting or read more.

There are a lot of pitfalls and common red flags that companies can avoid when trying to make a good first impression. These include assuming the investor is completely ignorant of the market, claiming their technology will address a whole market (such as ‘cancer’), claiming to have no competition, and claiming a KOL is involved in their company when they are not. Do not underestimate the investors you meet and expect them to take everything you say at face value – they are well informed, and, if they run into something they aren’t sure about, they will check.

LSN has developed a 4-step process on how to request meetings at a partnering conference.  LSN knows that just asking for a meeting will get you minimal results. We use the subject line of the email as a key starting point because if you use the subject as a tool to get attention and generate meetings if used properly.

4-Step, Subject Line Process that we have pioneered and works with astounding results. We have tested this process hundreds of times. The results are usually going from 3-7 meetings to 12-20+ meetings just by having your story and narrative crisp and using our LSN meeting request process. The 4-Step, Subject Line process that starts with putting the following in the subject line.

  • First Attempt for RESI Meeting: Introduction meeting request of XYZ company at Up-and-coming RESI event
  • Second Attempt for RESI Meeting: XYZ Companies Founders, Management Team, KOLs, and How XYZ Make a Difference
  • Third Attempt for RESI Meeting: XYZ Company Innovative Technology Asset and Market Position
  • Fourth and Final Attempt for RESI Meeting: XYZ Company Strategic Partners and Current Projects

Remember that when launching and positioning your company you are going on a journey from regional to global. Sign up for the LSN classes that are available to help with your branding and messaging. LSN curriculum specifically revolves around Global Roadshow Preparation, getting a company’s story straight, developing a compelling narrative, canvassing a global target list of capital investors and licensing partners, and follow-up. RESI partnering events bring the LSN ecosystem to life and afford startups the opportunity to meet strategic partners five times a year which is a crucial aspect as the transaction does not get done by attending 1-2 events a year.

LSN’s Redefining Early Stage Investments (RESI) Conference series is a terrific opportunity to network and make connections with key players that can help move your company to the next phase. The RESI conference series, because of its unique focus and format, is by far the best opportunity for early-stage companies to meet and partner with investors and strategics. Partnering opens February 21 for Digital RESI, March 14-16 and your degree of success is directly proportionate to the effort you put into it.

Digital RESI March 2023 Email Banner.(NEWtouse)